Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.
Can kratom (Mitragyna speciosa) alleviate COVID-19 pain? A case study / Metastasio, A.; Prevete, E.; Singh, D.; Grundmann, O.; Prozialeck, W. C.; Veltri, C.; Bersani, G.; Corazza, O.. - In: FRONTIERS IN PSYCHIATRY. - ISSN 1664-0640. - 11:(2020), pp. 1-6. [10.3389/fpsyt.2020.594816]
Can kratom (Mitragyna speciosa) alleviate COVID-19 pain? A case study
E. PreveteSecondo
Membro del Collaboration Group
;G. BersaniPenultimo
Conceptualization
;O. CorazzaUltimo
Conceptualization
2020
Abstract
Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.File | Dimensione | Formato | |
---|---|---|---|
Metastasio_Can-kratom_2020.pdf
accesso aperto
Note: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.594816/full
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
199.79 kB
Formato
Adobe PDF
|
199.79 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.